Loading…
Loading…
LH · NYSE · Healthcare
“At 25 times earnings, Laboratory Corp's valuation appears stretched relative to its clinical testing fundamentals, offering little margin of safety for prudent investors.”
— In the voice of Graham
Year-to-date total return including price appreciation. Compare performance against the S&P 500 benchmark.
Market Cap
$22.04B
P/E Ratio
25.14
Forward P/E
—
EPS
$10.54
PEG Ratio
1.54
Book Value
$103.98
Dividend Yield
1.09%
Profit Margin
6.28%
ROE
10.17%
Use the interactive ytd return with pre-loaded data for Laboratory Corp Of America Holdings. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for LH: